Spectrum and nosology: Implications for DSM-V

Psychiatric Clinics of North America

Volumn 25, Issue 4, 2002, Pages 855-885

  Maser, Jack D ^a,b   Patterson, Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISTRESS SYNDROME; HUMAN; HUMAN RELATION; MEDICAL EDUCATION; NOMENCLATURE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TREATMENT INDICATION;

HUMANS; MANUALS; MENTAL DISORDERS;

EID: 0036889749     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(02)00022-9     Document Type: Review

References (113)

1. th Edition. Washington, DC: American Psychiatric Association; 2000.
2. Ivanovs N, Marshall T. DSM-V research planning process. Psychiatric Research Report 2001;17:6.
3. Ivanovs N, Marshall T. DSM-V research planning work group summaries. Psychiatric Research Report 2001;17:7-8.
4. McHugh PR. Beyond DSM-IV: From appearances to essences. Psychiatric Research Report 2001;17:2-3,14-15.
5. Widiger TA, Clark LA. Toward DSM-V and the classification of psychopathology. Psychol Bull 2000;126:946-63.
6. Akiskal HS. Dysthymic disorder: Psychopathology of proposed chronic depressive subtypes. Am J Psychiatry 1983;140:11-20.
7. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J Clin Psychopharmacol 1996;16(2 Suppl 1):4S-14S.
8. Akiskal HS. The bipolar spectrum: The shaping of a new paradigm in psychiatry. Curr Psychiatry Rep 2002;4:1-3.
9. Akiskal HS, Pinto O. The evolving bipolar spectrum: Prototypes I, II, III, and IV. Psychiatr Clin N Am 1999;22:517-34.
10. Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry 1998;35(Suppl):7-12.
11. Hollander E, Rosen J. Impulsivity. J Psychopharmacol 2000;14(2 Suppl 1):S39-44.
12. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995;56(Suppl 4):3-6.
13. Hudson JI, Pope HG Jr. Affective spectrum disorder: Does antidepressant response identify a family of disorders with a common psychopathology? Am J Psychiatry 1990;147:552-64.
14. McElroy SL, Keck PE Jr, Phillips KA. Kleptomania, compulsive buying, and binge eating disorder. J Clin Psychiatry 1995;56(Suppl 4):14-26.
15. Winokur G. Depression spectrum disease: Description and family study. Compr Psychiatry 1972;13:3-8.
16. Kraepelin E. Manic-Depressive Insanity and Paranoia. Translated by RM Barclay, GM Robertson, editors. Edinburgh: E & S Livingston; 1921.
17. Hollander E. Introduction. In: Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press Inc.; 1993.
18. Wakefield JC. The concept of mental disorder: On the boundary between biological facts and social values. Am Psychol 1992;47:373-88.
19. Wakefield JC. Disorder as harmful dysfunction: A conceptual critique of DSM-III-R's definition of mental disorder. Psychol Rev 1992;99:232-47.
20. Wakefield JC. Evolutionary versus prototype analyses of the concept of disorder. J Abnorm Psychol 1999;108:374-99.
21. Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: Does it help solve the false positives problem? Am J Psychiatry 1999;156:1856-64.
22. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States. Arch Gen Psychiatry 2002;59:115-23.
23. rd Edition. Washington, DC: American Psychiatric Association; 1980.
24. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Muñoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
25. rd Edition. New York: New York State Psychiatric Institute, Biometrics Research; 1978.
26. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria. New York: New York State Psychiatric Institute, Biometrics Research; 1975.
27. Coryell W, Zimmerman M. Progress in the classification of functional psychoses. Am J Psychiatry 1987;144:1471-4.
28. rd Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
29. Klerman GL. Approaches to the phenomena of comorbidity. In: Maser JD, Cloninger CR, editors. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990. p. 13-37.
30. First MB, Pincus HA. Classification in psychiatry: ICD-10 v. DSM-IV. Br J Psychiatry 1999;175:205-9.
31. th edition. Geneva: World Health Organization; 1993.
32. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptors and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
33. th Revision. Ann Arbor: Edwards Brothers; 1978.
34. Maser JD, Kaelber C, Weise R. International use and attitudes toward DSM-III and DSM-III-R: Growing consensus in psychiatric classification. J Abnorm Psychol 1991;100: 271-9.
35. Frances A, Clarkin JF, Perry S. DSM-III and family therapy. Am J Psychiatry 1984;141: 406-9.
36. Kirk SA, Kutchins H. The Selling of DSM: The Rhetoric of Science in Psychiatry. New York: Aldine de Gruyter; 1992.
37. Klerman GL. Vaillant GE, Spitzer RL, Michels R. A debate on DSM-III. Am J Psychiatry 1984;141:539-53.
38. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin N Am 2001;24:19-39.
39. McHugh PR, Slavney PR. The Perspectives of Psychiatry. Baltimore: The Johns Hopkins University Press; 1983.
40. Richters JE, Cicchetti D. Mark Twain meers DSM-III-R: Conduct disorder, development, and the concept of harmful dysfunction. Development and Psychopathology 1993;5: 5-29.
41. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134: 1227-33.
42. Akiskal HS. External validating criteria for psychiatric diagnosis: Their application in affective disorders. J Clin Psychiatry 1980;41(12 Pt 2):6-15.
43. Kendler KS, Gruenberg AM, Strauss JS. An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. 11. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 1981;38:982-4.
44. nd Maudsley lecture] Br J Psychiatry 1980; 136:421-36.
45. Cassano GB, Banti S, Mauri M, Dell'Osso L, Miniati M, et al. Internal consistency and discriminant validity of the Structured Clinical Interview for Panic Agoraphobic Spectrum (SCI-PAS). International Journal of Methods in Psychiatric Research 1999;8:138-45.
46. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970;23:455-68.
47. Andrews G. Comorbidity and the general neurotic syndrome. Br J Psychiatry 1996; 30 (Suppl):76-84.
48. Brieger P. Comorbidity in bipolar affective disorder. In: Marneros A, Angst J, editors. Bipolar Disorders: 100 Years After Manic Depressive Insanity. Dordrecht (The Netherlands): Kluwer Academic Publishers; 2000. p. 215-29.
49. Fyer AJ, Liebowitz MR, Klein DF. Treatment trials, comorbidity, and syndromal complexity. In: Maser JD, Cloninger CR, editors. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990. p. 669-79.
50. Maser JD, Cloninger CR. Comorbidity of anxiety and mood disorders: Introduction and overview. In: Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990. p. 3-12.
51. Ekselius L, Lindstrom E, von Knorring L, Bodlund O, Kullgren G. Personality disorders in DSM-III-R as categorical or dimensional. Acta Psychiatr Scand 1993;88:183-7.
52. Marinangeli MG, Butti G, Scinto A, Di Cicco L, Petruzzi C, Daneluzzo E, et al. Patterns of comorbidity among DSM-III-R personality disorders. Psychopathology 2000;33: 69-74.
53. Schroeder ML, Livesley WJ. An evaluation of DSM-III-R personality disorders. Acta Psychiatr Scand 1991;84:512-9.
54. Watson DC, Sinha BK. Comorbidity of DSM-IV personality disorders in a nonclinical sample. J Clin Psychol 1998;54:773-80.
55. Perugi G, Akiskal HS, Ramacciotti S, Nassini S, Toni C, Milanfranchi A, et al. Depressive comorbidity of panic, social phobia, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection? J Psychiatr Res 1999;33:53-61.
56. Angst J. Comorbidity of mood disorders: A longitudinal prospective study. Br J Psychiatry 1996;30 (Suppl):31-7.
57. Heninger GR. A biologic perspective on comorbidity of major depressive disorder and panic disorder. In: Maser JD, Cloninger CR, editors. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990. p. 381-401.
58. Poland RE. Interpretative aspects of biological markers in psychiatry in relation to issues of comorbidity. In: Maser JD, Cloninger CR, editors. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990. p. 403-11.
59. Van Praag HM. Comorbidity (psycho) analyzed. Br J Psychiatry 1996;168(Suppl 30): 129-34.
60. DSM-IV Text Revision [61] Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, et al. Subthreshold psychiatric disorders in primary care: Prevalence and associated characteristics. J Affect Disord, in press.
61. Arnstein RL. Survey of DSM-III use. J Am Coll Health 1983;32:110-13.
62. Horton AD, Retzlaff PD. Family assessment: Toward DSM-III-R relevancy. J Clin Psychol 1991;47:94-100.
63. Denton WH, Patterson JE, Van Meir ES. Use of the DSM in marriage and family therapy programs: Current practices and attitudes. J Marital Fam Ther 1997;23:81-6.
64. Kaslow FW. Relational diagnosis: An idea whose time has come? Fam Process 1993;32: 255-9.
65. Shear MK, Greeno C, Kang J, Ludewig D, Frank E, Swartz HA, et al. Diagnosis of nonpsychotic patients in community clinics. Am J Psychiatry 2000;157:581-7.
66. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York: International University Press; 1911/1950.
67. Jeste DV, Kleinman JE, Potkin SG, Luchins DJ, Weinberger DR. Ex uno multi: Subtyping the schizophrenic syndrome. Biol Psychiatry 1982;17:199-222.
68. McDermut W, Mattia J, Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affect Disord 2001;65:289-95.
69. Cassano GB, Michelini S, Shear MK, Coli E, Maser JD, Frank E. The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms. Am J Psychiatry 1997;154:27-38.
70. Kendler KS, Neale MC, Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry 1995;52:749-54.
71. Lichtermann D, Karbe E, Maier W. The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 2000;250:304-10.
72. Clark LA, Livesley WJ, Morey L. Personality disorder assessment: The challenge of construct validity. J Personal Disord 1997;11:205-31.
73. Cloninger CR. A practical way to diagnose personality disorders. J Personal Disord 2000;14:99-108.
74. Eysenck HJ. A dimensional system of psychodiagnosis. In: Mahrer AR, editor. New Approaches to Personality Classification. New York: Columbia University Press; 1970. p. 169-207.
75. Livesley WJ, Jang KL. Toward an empirically based classification of personality disorder. J Personal Disord 2000;14:137-51.
76. Oldham JM, Skodol AE. Charting the future of Axis II. J Personal Disord 2000;14:17-29.
77. Ryder AG, Bagby RM, Dion KL. Chronic, low-grade depression in a non-clinical sample: Depressive personality or dysthymia? J Personal Disord 2001;15:84-93.
78. Ulrich S, Borkenau P, Marneros A. Personality disorders in offenders: Categorical versus dimensional approaches. J Personal Disord 2001;15:442-9.
79. st century. J Personal Disord 2000;14:3-16.
80. Widiger TA, Frances A. Axis II personality disorders: Diagnostic and treatment issues. Hosp Community Psychiatry 1985;36:619-27.
81. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-32.
82. Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressant and placebo: An analysis of the food and drug administration database. J Clin Psychopharmacol 2002;22:40-5.
83. Paykel ES, Hollyman JA, Freeling P, Segdwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo- controlled trial. J Affect Disord 1988;14:83-95.
84. Judd LL, Rapaport MH, Paulus MP, Brown JL. Subsyndromal symptomatic depression: A new mood disorder? J Clin Psychiatry 1994;55(Suppl):18-28.
85. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55:694-700.
86. Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-4.
87. Lewis A. Prognosis in the manic-depressive psychosis. Lancet 1936;2:997-9.
88. Judd LL, Akiskal HS, Zeller P, Paulus M, Leon AC, Maser JD, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000;57:375-80.
89. First M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Disorders: Patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996.
90. Rucci P, Maser JD. Instrument development in the Italy-USA collaborative spectrum project. Epidemiol Psichiatr Soc 2000;9:249-56.
91. Cox BJ, Enns MW, Borger SC, Parker JDA. The nature of the depressive experience in analogue and clinically depressed samples. Behav Res Ther 1999;37:15-24.
92. Enns MW, Cox BJ, Borger SC. Correlates of analogue and clinical depression: A further test of the phenomenological continuity hypothesis. J Affect Disord 2001;66(2-3): 175-83.
93. Gotlib IH, Lewinsohn PM, Seeley JR. Symptoms versus a diagnosis of depression: Differences in psychosocial functioning. J Consult Clin Psychol 1995;63:90-100.
94. Flett GL, Vredenburg K, Krames L. The continuity of depression in clinical and nonclinical samples. Psychol Bull 1997;121:395-416.
95. Angst J, Merikangas KR, Preisig M. Subthreshold syndromes of depression and anxiety in the community. J Clin Psychiatry 1997;58(Suppl 8):6-10.
96. Berardi D, Berti Ceroni G, Leggieri G, Rucci P, Ustun B, Ferrari G. Mental, physical and functional status in primary care attenders. Int J Psychiatry Med 1999;29:133-48.
97. Pincus HA, Davis WW, McQueen LE. Subthreshold mental disorders: A review and synthesis of studies on minor depression and other brand names. Br J Psychiatry 1999; 174:288-96.
98. Wittchen HU, Fuetsch M, Sonntag H, Müller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia: Findings from a controlled study. Eur Psychiatry 2000;15:46-58.
99. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992;267:1478-83.
100. Waern M, Runeson BS, Allebeck P, Beskow J, Rubenowitz E, Skoog I, et al. Mental disorder in elderly suicides: A case-control study. Am J Psychiatry 2002;159:450-5.
101. Thaker G, Adami H, Gold J. Functional deterioration in individuals with schizophrenia spectrum personality symptoms. J Personal Disord 2001;15:229-34.
102. Pini S, Perkonnig A, Tansella M, Wittchen HU. Prevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care. J Affect Disord 1999;56: 37-48.
103. Lin EH, Katon WJ, Von Korff M, Russo JE, Simon GE, Bush TM, et al. Relapse of depression in primary care: Rate and clinical predictors. Arch Fam Med 1998;7:443-9.
104. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J. Long-term outcome of episodes of major depression: Clinical and public health significance. JAMA 1984;252:788-92.
105. Horwath E, Johnson J, Klerman GL, Weissman MM. Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 1992;49:817-23.
106. Lewinsohn PM, Solomon A, Seeley JR, Zeiss A. Clinical implications of "subthreshold" depressive symptoms. J Abnorm Psychol 2000;109:345-51.
107. Merikangas KR, Avenevoli S, Acharyya S, Zhang H, Angst J. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry 2002;51:81-91.
108. Stein MB, Torgrud LJ, Walker JR. Social phobia symptoms, subtypes, and severity. Arch Gen Psychiatry 2000;57:1046-51.
109. Bech P, Rasmussen N, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001;66(2-3):159-64.
110. Sansone RA, Wiederman MW, Sansone LA, Touchet B. An investigation of primary care patients receiving extended treatment with selective serotonin reuptake inhibitors. American Journal of Managed Care 1998;4:1397-402.
111. Niculescu AB III, Akiskal HS. Proposed endophenotypes of dysthymia: Evolutionary, clinical and pharmacogenomic considerations. Mol Psychiatry 2001;6:363-6.
112. Wacker HR. Epidemiology and comorbidity of depressive disorders. Ther Umsch 2000; 57:53-8.
113. Goodman WK, Rudorfer MV, Maser JD, editors. Obsessive Compulsive Disorder: Contemporary Issues in treatment. Mahwah (NJ): Lawrence Erlbaum Associates; 2000.